diabetestalk.net

Immune System Research Could Bring New Treatments For MS, Diabetes

Immune System Research Could Bring New Treatments for MS, Diabetes

Immune System Research Could Bring New Treatments for MS, Diabetes

In autoimmune disorders, malfunctioning immune cells turn against the body.
These cells attack the protective sheaths that surround neurons in the brain, which can eventually lead to a host of symptoms and conditions like paralysis, and in some cases be fatal.
Now, imagine if these wayward cells could be influenced to control the disease, rather than fuel it.
Research presented today at a meeting of the American Chemical Society (ACS) shows that it’s possible — and could be a game-changer — when it comes to treating autoimmune diseases like multiple sclerosis (MS) and type 1 diabetes.
Read more: Get the facts on autoimmune diseases »
Current methods imprecise
While current immunotherapies can yield positive results, they tend to deal in broad strokes.
This approach can affect and potentially compromise the entire immune system, rather than dealing with just the cells that are causing problems.
Christopher Jewell, PhD, associate professor in the bioengineering department at the University of Maryland, and lead researcher on the study released today, told Healthline that his team set out to develop a form of immunotherapy that specifically targeted the problematic cells, leaving the rest of the immune system alone.
“We are working on autoimmune disease, where the body’s immune system mistakenly recognizes and attacks its own cells or tissues,” Jewell wrote in an email. “In multiple sclerosis, myelin — the matrix that insulates neurons — gets attacked by malfunctioning immune cells entering the brain. Existing therapies have been beneficial for patients, but Continue reading

Rate this article
Total 1 ratings
Could Broccoli Sprouts Help Treat Type 2 Diabetes?

Could Broccoli Sprouts Help Treat Type 2 Diabetes?


Could Broccoli Sprouts Help Treat Type 2 Diabetes?
The next big diabetes drug may have been sitting in the salad bar all along. Researchers say concentrated broccoli sprout extract could be an excellent tool for regulating blood glucose in people with Type 2 diabetes (T2D). They published their findings in the journal Science Translational Medicine.
Scientists have been interested in broccoli sprout extract (BSE) for some time now. The active ingredient, a compound called sulforaphane (SFN), has already been tested as a potential treatment for a number of conditions, including cancer and chronic obstructive pulmonary disease.
Nobody had considered SFN for diabetes before. The authors of the current study werent even considering it. They had just been looking for existing drugs that matched T2Ds genetic signature. Out of 3852 different compounds, just a few possible leads emerged. The most promising among them was SFN.
The researchers took that lead and ran with it. They tested the compounds effects on the liver and blood sugar in not one, but a whole bunch of settings, starting with computer models of genes, then moving to liver cells cultured in the lab, then mice and rats.
The results of each experiment informed the next oneand the results were promising. SFN seemed to reduce glucose production in liver cells and change T2D gene expression in rats.
Finally, the researchers moved into testing the drug on people. They recruited 103 obese people with hard-to-manage T2D at a Swedish hospital and tested how well each persons body metabolized glucose. For 12 weeks, stud Continue reading

Adults being diagnosed with the wrong diabetes, study finds

Adults being diagnosed with the wrong diabetes, study finds


Adults being diagnosed with the wrong diabetes, study finds
By Katie Silver Health reporter, BBC News
These are external links and will open in a new window
Image caption Helen Philibin was misdiagnosed with Type 2 diabetes
Many might think type 1 diabetes is a "disease of childhood", but research, published in the Lancet Diabetes & Endocrinology, has found it has similar prevalence in adults.
More than 40% of Britons diagnosed with the condition are over 30.
Many of these are initially diagnosed with type 2, and receiving the wrong treatment can be life-threatening.
Charity Diabetes UK is calling for doctors not to rule out the possibility a patient over 30 might have type 1.
Helen Philibin, a mother of two from Torquay, who was 40, slim and active when she was diagnosed.
She said: "Having the wrong diagnosis was extremely frustrating. I just knew it wasn't right.
"I'm always running around with my two young kids and I walk the dog every day."
She visited her GP complaining of extreme thirst. A blood test strongly indicated she had diabetes.
Her doctor diagnosed her with type 2 and prescribed metformin, the most commonly-used drug for the condition. She was also sent on a course to learn about lifestyle factors including a low-sugar diet.
"All the other people on the course were in their mid-60s and overweight. I was 5ft 10in and nine-and-a-half stone. I stood out like a sore thumb," said Helen.
"When I raised it with nurses or my GP, I was told that type 1 diabetes is always diagnosed in childhood, so I had to be type 2. I felt like I was banging my head Continue reading

Congress must extend critical federal funding for type 1 diabetes research

Congress must extend critical federal funding for type 1 diabetes research

While Congress debates healthcare and insurance markets, it’s easy to forget that the government plays a special role in research that helps millions of Americans live fuller lives. Indeed, the National Institutes of Health (NIH) and other agencies are the largest sources of health research funding — not just in the United States, but worldwide — with the money used to develop therapies and find cures for the diseases that most afflict Americans.
More than 1.25 million people in the U.S. live with type 1 diabetes (T1D); constant control of their disease is critical to survival. The Special Diabetes Program (SDP) at the NIH has long had bipartisan support and has delivered life-changing therapies allowing many more Americans to live longer, healthier lives.
This week, my son Jonathan and I are back in Washington, D.C. with JDRF, the leading organization that funds T1D research, for its Children’s Congress, urging the House and Senate to renew the SDP for another three years. Because of federal funding for diabetes research by the SDP, there has been significant progress for better treatments. It has shown tangible results by helping scientists make significant advances in prevention studies, treatments and research to achieve the ultimate objective: a cure.
I’ll never forget the moment, just a year ago, when Jonathan’s physician told us he had a spot on a clinical trial for the first-generation “artificial pancreas,” the first system to automatically dose insulin to improve blood sugar management. It dramatically improves the lives of people with T1D -— and Continue reading

Health Insurance Plan for Diabetes Patients: Check out 3 of the best insurance policies available inIndia

Health Insurance Plan for Diabetes Patients: Check out 3 of the best insurance policies available inIndia


Health Insurance Plan for Diabetes Patients: Check out 3 of the best insurance policies available inIndia
Health Insurance Plan for Diabetes Patients: Check out 3 of the best insurance policies available inIndia
Many insurance companies have planned their policies keeping lifestyle diseases like diabetes in mind.
The premiums of health policies for diabetic patients are also different from other health policies.
Delhi pollution: As CM Arvind Kejriwal cries over stubble burning, AAP leader sets fields on fire in Punjab
Diabetes is one of those diseases which need medication on a regular basis. Worse, medical expenses for diabetes are more than many other such diseases. Also, with inflation and lifestyle costs rising, managing expenses for medication of this disease is not easy. Here comes the importance and need for health insurance policies for diabetes being offered by several insurance companies in the market.
Many insurance companies have planned their policies keeping lifestyle diseases like diabetes in mind. The premiums of such plans are also different from other general insurance policies. As diabetes falls under the high risk category of diseases, finding the most suitable insurance policy pertaining to the needs and requirement of the insurance seeker and with the lowest premium is not easy.
Here we are taking a look at some of the best insurance policies in India for diabetic patients:
1. Diabetes Safe Insurance Policy Star Health Insurance Co
Offered by Star Health Insurance Company for diabetics patients, this policy provides individual and floater ( Continue reading

No more pages to load

Popular Articles

  • Study Links Vaccine Induced Immune Overload to Autism, Diabetes, Obesity

    A new vaccine study published in Molecular and Genetic Medicine is bringing to the forefront the disturbing connection between the dramatic expansion in the quantity of routine childhood vaccines administered and a corresponding increase in inflammation-associated disorders. Titled, "Review of Vaccine Induced Immune Overload and the Resulting Epidemics of Type 1 Diabetes and Metabolic Syndrome, Em ...

  • History of diabetes: Past treatments and new discoveries

    Diabetes is a condition characterized by high blood sugar levels. It affects millions of people around the world. Research into diabetes is ongoing but diabetes is simple to manage for most people. Since diabetes was first discovered, there have been huge improvements in the way it is treated. This article looks at the history of diabetes and how these treatments developed. Contents of this articl ...

  • Are You Staying Informed With New Diabetes Treatments?

    Poll finds less than half of health care professionals aware of newest drug up for FDA approval. By Steve Freed, R.Ph., Diabetes Educator, Publisher In the past two years, more than 30 medications have come to the market, and more than 475 additional diabetes drugs are in the works to get approved. To test the knowledge of endocrinologists, 149 endocrinologists responded to a survey about a new dr ...

  • Gut molecule that blocks ‘hunger hormone’ may spur new treatments for diabetes, anorexia

    Scientists once had high hopes that inhibiting a hormone named ghrelin would be the key to preventing obesity. Ghrelin didn’t turn out to be a weight loss panacea. But now, the discovery of the first molecule naturally made by the body that blocks ghrelin’s effects may open up new avenues for treating other conditions, including diabetes and anorexia. The finding may also explain some of the b ...

  • Google and Sanofi Will Bring Diabetes Care to the Cloud

    Google, along with French pharmaceutical company Sanofi, announced today a partnership that will help improve care for patients with diabetes. According to Andy Conrad, head of Google's life science unit, technology can go a long way in helping treat both the minor and major complications that go along with having diabetes. “Diabetics are far more likely to have heart attacks, they’re far more ...

  • One Drop Partners with Fitbit to Bring Diabetes Management Data Insights to Users Worldwide

    One Drop Partners with Fitbit to Bring Diabetes Management Data Insights to Users Worldwide One Drop users gain 24/7 access to Fitbit data in combination with One Drop health data to drive more comprehensive care management experience One Drop to develop custom app for Fitbit Ionic providing diabetes-related health data on wrist for users of both Android and iOS devices NEW YORK, Oct. 31, 201 ...

  • Diabetes drug could help those living with Parkinson's disease, research reveals

    A drug commonly used to treat diabetes could help those living with Parkinson’s disease, research has revealed. By 2020 it is predicted that 162,000 individuals in the UK will be living with the condition. While existing drugs help to control its symptoms, there are currently none available which slow or halt its progression. But now scientists say they have found that a drug commonly used to tr ...

  • Research suggests type 2 diabetes could be transmitted like mad cow disease

    2 pictures It is estimated that about 6 percent of the world's population suffers from type 2 diabetes. Labelled a global health epidemic by the World Health Organization, rates of the disease increased dramatically from about 30 million cases in 1985 to around 390 million by 2015. A new study has now found a previously undiscovered mechanism that raises the possibility of type 2 diabetes being tr ...

  • UTHealth research: Misfolded form of pancreatic protein could induce type 2 diabetes symptoms

    HOUSTON – (Aug. 1, 2017) – The symptoms of type 2 diabetes can be induced by a misfolded form of a pancreatic protein and possibly be transmitted by a mechanism similar to prion diseases such as Creutzfeldt-Jakob disease or bovine spongiform encephalopathy (mad cow disease), according to researchers from McGovern Medical School at The University of Texas Health Science Center at Houston (UTHea ...

Related Articles